EUVIMEDEUVIMED entdecken
Fallbericht

Multiple Lineage Switches in a Pediatric Case With a KMT2A::AFF1 ‐Positive Acute Lymphoblastic Leukemia: How Cell Plasticity Induces Immunotherapy Failure

Luca Lo Nigro iD, Marta Arrabito, Emanuela Cannata, Manuela La Rosa, Valeria Iachelli, Paola Bonaccorso

Pediatric Blood & Cancer · 2025-10 · 72 (10)

DOI: 10.1002/pbc.31950 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Blood & Cancer, 2025-08. Verfasst von Luca Lo Nigro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Pediatric Hematology Oncology, Azienda Policlinico, G. Rodolico, Catania, Italy. Hauptthemen laut MEDLINE: Histone-Lysine N-Methyltransferase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myeloid-Lymphoid Leukemia Protein, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Associazione Italiana Ricerca sul Cancro, IBISCUS-ets.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a case of multiple lineage switches (rare events mostly occurring in infants) in a 10‐year‐old female with KMT2A::AFF1 ‐positive acute lymphoblastic leukemia (ALL). Although she underwent standard chemotherapy, immunotherapy, and hematopoietic stem cell transplantation, the leukemic clone continuously switched on acute myeloid leukemia (AML) or ALL and maintained immunoglobulin/T‐cell receptor rearrangements in addition to showing a high therapy‐escaping grade. As other genes are involved in this event, and after considering the selective pressure imposed by the applied treatment, characterizing the cell‐of‐origin that is capable of proliferating toward both lineages while attempting to design targeted therapies is mandatory.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone-Lysine N-MethyltransferasePrecursor Cell Lymphoblastic Leukemia-LymphomaMyeloid-Lymphoid Leukemia ProteinImmunotherapyTranscriptional Elongation FactorsCell LineageHumansFemaleChildHematopoietic Stem Cell TransplantationDNA-Binding Proteins

Stichwörter der Autor:innen

KMT2A/MLL rearrangementsacute lymphoblastic leukemiaacute myeloid leukemiachildrenlineage switch

Substanzen

Histone-Lysine N-MethyltransferaseMyeloid-Lymphoid Leukemia ProteinKMT2A protein, humanAFF1 protein, humanTranscriptional Elongation FactorsDNA-Binding Proteins

Autor:innen und Institutionen

  • Center of Pediatric Hematology Oncology, Azienda Policlinico, G. Rodolico, Catania, Italy.
  • Cytofluorimetric-Cytogenetic-Molecular Biology Laboratory, Center of Pediatric Hematology-Oncology, Azienda Policlinico, G. Rodolico, Catania, Italy.

ORCID-Profile: Luca Lo Nigro

Förderung

  • Associazione Italiana Ricerca sul Cancro
  • IBISCUS-ets

Zitieren

APA

Lo Nigro, L., Arrabito, M., Cannata, E., La Rosa, M., Iachelli, V., & Bonaccorso, P. (2025). Multiple Lineage Switches in a Pediatric Case With a KMT2A::AFF1 ‐Positive Acute Lymphoblastic Leukemia: How Cell Plasticity Induces Immunotherapy Failure. Pediatric Blood & Cancer, 72(10). https://doi.org/10.1002/pbc.31950

Vancouver

Lo Nigro L, Arrabito M, Cannata E, La Rosa M, Iachelli V, Bonaccorso P. Multiple Lineage Switches in a Pediatric Case With a KMT2A::AFF1 ‐Positive Acute Lymphoblastic Leukemia: How Cell Plasticity Induces Immunotherapy Failure. Pediatric Blood & Cancer. 2025;72(10). doi:10.1002/pbc.31950

BibTeX
@article{LoNigro2025,
  author = {Lo Nigro, Luca and Arrabito, Marta and Cannata, Emanuela and La Rosa, Manuela and Iachelli, Valeria and Bonaccorso, Paola},
  title = {Multiple Lineage Switches in a Pediatric Case With a KMT2A::AFF1 ‐Positive Acute Lymphoblastic Leukemia: How Cell Plasticity Induces Immunotherapy Failure},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  volume = {72},
  number = {10},
  doi = {10.1002/pbc.31950}
}
Kostenlos starten →